导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 2.76% | 1521/4773 |
| 近一周 | -2.67% | 2799/5462 |
| 近一月 | -4.30% | 2369/5421 |
| 近一季 | -10.08% | 3400/5209 |
| 近半年 | 0.14% | 1197/4920 |
| 近一年 | 4.66% | 1685/4366 |
| 近两年 | 108.91% | 494/2954 |
| 近三年 | 68.00% | 333/2253 |
| 成立以来 | -13.94% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
-5.21% 3782/4961 |
32.34% 990/5312 |
- - |
- - |
| 2025 | 34.54% 1037/4813 |
9.42% 393/3635 |
-3.78% 3456/4076 |
31.30% 1126/4524 |
-2.67% 3186/4813 |
| 2024 | 23.89% 315/3463 |
-7.58% 2173/2808 |
-0.11% 683/3014 |
13.67% 2136/3129 |
18.07% 81/3463 |
| 2023 | 9.61% 111/2656 |
23.07% 119/2280 |
-1.25% 459/2385 |
-8.13% 1666/2515 |
-1.83% 378/2655 |
| 2022 | -31.05% 1648/2207 |
-22.40% 1700/1919 |
3.13% 1210/2016 |
-16.05% 1395/2113 |
2.63% 877/2208 |
| 2021 | 7.77% 490/1822 |
-8.41% 1083/1255 |
15.29% 231/1330 |
-5.97% 887/1466 |
8.53% 150/1822 |
| 2020 | 12.94% 805/1250 |
-1.41% 215/1022 |
17.82% 356/1060 |
-0.41% 1047/1152 |
- - |
| 2019 | 49.86% 103/1092 |
38.47% 59/748 |
-11.46% 761/797 |
10.06% 48/844 |
11.06% 78/912 |
| 2018 | -33.96% 562/834 |
- - |
- - |
- - |
-12.35% 437/691 |
| 2017 | -5.72% 513/714 |
- - |
- - |
- - |
- - |
| 2016 | -24.67% 474/605 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 景顺长城中证港股通创新药ETF | 1.6507 | 28.23% |
| 港股医疗 | 0.9366 | 28.18% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 港股通医疗ETF工银 | 0.9464 | 28.06% |
| 港股通医疗ETF华宝 | 0.9577 | 27.97% |
| 天弘恒生沪深港创新药精选50ETF发起联接C | 1.2844 | 27.92% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 万家中证港股通创新药ETF发起式联接A | 1.3863 | 27.32% |
| 万家中证港股通创新药ETF发起式联接C | 1.3856 | 27.27% |
| 中信保诚中证智能家居指数(LOF)A VS. 长安沪深300非周期A(740101) |